Back to top

Bernstein Keeps Their Buy Rating on CVS Health (CVS)

In a report released today, Lance Wilkes from Bernstein maintained a Buy rating on CVS Health, with a price target of $106.00. Wilkes covers the He...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

CVS Health Corporation (CVS)